Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality

Xiang-Le Zhang1,2, Hong-Wei Yue1,2, Ya-Jun Liu1,2

  • 1Key Laboratory of RNA Innovation, Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, P.R. China.

Iscience
|March 19, 2025
PubMed

Insights

Engineered polyQ fusion proteins can sequester USP7 and HDM2, reactivating P53 signaling. This strategy shows therapeutic potential for cancer by modulating P53 stability and function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Protein Engineering

Background:

  • Overexpression of USP7 and HDM2 inactivates P53 signaling in tumor cells, promoting cancer progression.
  • Targeting USP7 and HDM2 to restore P53 function is a significant challenge in cancer therapy.

Purpose of the Study:

  • To engineer polyQ fusion proteins for specific sequestration of USP7 and HDM2.
  • To modulate P53 stability and functionality through targeted protein aggregation.

Main Methods:

  • Design and application of polyQ sequences fused with target-interacting peptides.
  • Engineering of designer fusion proteins, such as Atx793Q-N172-IRF and Atx793Q-N172-PMI.
  • Analysis of P53 level modulation and downstream gene expression.

Main Results:

  • The fusion protein Atx793Q-N172-IRF sequesters USP7 and/or HDM2, increasing P53 levels, with effects dependent on IRF repeats.
  • Depletion of USP7 availability by fusion proteins plays a dual role in controlling P53 stability.
  • Direct sequestration of HDM2 by Atx793Q-N172-PMI significantly reduces soluble HDM2, increasing P53 levels and up-regulating downstream gene expression.

Conclusions:

  • The polyQ-fusion strategy is a feasible approach to modulate P53 stability and functionality.
  • Engineered polyQ fusion proteins demonstrate therapeutic potential for cancer treatment by targeting USP7 and HDM2.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.6K